Thyrotoxicosis and the cardiovascular system: Subtle but serious effects

Cleveland Clinic Journal of Medicine

Volumn 70, Issue 1, 2003, Pages 57-63

  Roffi, Marco ^a   Cattaneo, Fabio ^c   Topol, Eric J ^b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b LERNER RESEARCH INSTITUTE   (United States)

^c NONE

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTITHYROID AGENT; ATENOLOL; BETA 1 ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; CONTRAST MEDIUM; CORTICOSTEROID; DILTIAZEM; LIOTHYRONINE; LITHIUM; METOPROLOL; POTASSIUM PERCHLORATE; PROPRANOLOL; PROPYLTHIOURACIL; RADIOACTIVE IODINE; THIAMAZOLE; THIONAMIDE; THYROID HORMONE; THYROXINE; VERAPAMIL;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR SYMPTOM; CARDIOVASCULAR SYSTEM; CLINICAL FEATURE; DISEASE ASSOCIATION; DRUG WITHDRAWAL; DYSPNEA; EXERCISE TOLERANCE; HEART ARRHYTHMIA; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART PALPITATION; HUMAN; MORBIDITY; MORTALITY; REVIEW; SINUS TACHYCARDIA; SUBTOTAL THYROIDECTOMY; SYMPTOM; THROMBOEMBOLISM; THYROTOXICOSIS; WEIGHT REDUCTION;

EID: 0037242924     PISSN: 08911150     EISSN: None     Source Type: Journal    
DOI: 10.3949/ccjm.70.1.57     Document Type: Review

References (34)

1. Franklyn JA, Maisonneuve P, Sheppard MC, Betteridge J, Boyle P. Mortality after the treatment of hyperthyroidism with radioactive iodine. N Engl J Med 1998; 338:712-718.
2. Leese GP, Jung RT, Guthrie G, Waugh N, Browning MC. Morbidity in patients on L-thyroxine: a comparison of those with a normal TSH to those with a suppressed TSH. Clin Endocrinol 1992; 37:500-503.
3. Klein I, Levey GS. The cardiovascular system in thyrotoxicosis. In: Braverman LE, Utiger RD, editors. Werner & Ingbar's The Thyroid: A Fundamental and Clinical Text, 8th ed. Philadelphia: Lippincott Williams & Wilkins, 2000:596-604.
4. Roffi M. Endocrine systems and the heart. In: Topol EJ, editor. Textbook of Cardiovascular Medicine, 2nd ed. New York: Lippincott Williams & Wilkins, 2002:765-780.
5. Polikar R, Burger AG, Scherrer U, Nicod P. The thyroid and the heart. Circulation 1993; 87:1435-1441.
6. Klein I, Ojamaa K. Thyroid hormone and the cardiovascular system. N Engl J Med 2001; 344:501-509.
7. Sanford CF, Griffin EE, Wildenthal K. Synthesis and degradation of myocardial protein during the development and regression of thyroxine-induced cardiac hypertrophy in rats. Circ Res 1978; 43:688-694.
8. Biondi B, Palmieri EA, Fazio S, et al. Endogenous sub-clinical hyperthyroidism affects quality of life and cardiac morphology and function in young and middle-aged patients. J Clin Endocrinol Metab 2000; 85:4701-4705.
9. Woeber KA. Thyrotoxicosis and the heart. N Engl J Med 1992; 327:94-98.
10. Forfar JC, Miller HC, Toft AD. Occult thyrotoxicosis: a correctable cause of "idiopathic" atrial fibrillation. Am J Cardiol 1979; 44:9-12.
11. Krahn AD, Klein GJ, Kerr CR, et al. How useful is thyroid function testing in patients with recent-onset atrial fibrillation? The Canadian Registry of Atrial Fibrillation Investigators. Arch Intern Med 1996; 156:2221-2224.
12. Sawin CT, Geller A, Wolf PA, et al. Low serum thyrotropin concentrations as a risk factor for atrial fibrillation in older persons. N Engl J Med 1994; 331:1249-1252.
13. Park KW, Dai HB, Ojamaa K, et al. The direct vasomotor effect of thyroid hormones on rat skeletal muscle resistance arteries. Anesth Analg 1997; 85:734-738.
14. Ebisawa K, Ikeda U, Murata M, et al. Irreversible cardiomyopathy due to thyrotoxicosis. Cardiology 1994; 84:274-277.
15. Cavallo A, Joseph CJ, Casta A. Cardiac complications in juvenile hyperthyroidism. Am J Dis Child 1984; 138:479-482.
16. Bauerlein EJ, Chakko CS, Kessler KM. Reversible dilated cardiomyopathy due to thyrotoxicosis. Am J Cardiol 1992; 70:132.
17. Sachs RN, Valensi P. Reversible cardiomyopathy due to thyrotoxicosis. Am J Cardiol 1993; 71:501.
18. Bar-Sela S, Ehrenfeld M, Eliakim M. Arterial embolism in thyrotoxicosis with atrial fibrillation. Arch Intern Med 1981; 141:1191-1192.
19. Feroze M, May H. Apathetic thyrotoxicosis. Int J Clin Pract 1997; 51:332-333.
20. Pinede L, Ninet J, Duhaut P, et al. Severe digital ischemia disclosing Basedow's disease: 2 cases. Rev Med Interne 1997; 18:806-808.
21. Schumacher B, Lüderlitz B. Rate issues in atrial fibrillation: consequences of tachycardia and therapy for rate control. Am J Cardiol 1998; 82:29N-36N.
22. Harjai KJ, Licata AA. Effects of amiodarone on thyroid function. Ann Intern Med 1997; 126:63-73.
23. Martino E, Safran M, Aghini-Lombardi F, et al. Environmental iodine intake and thyroid dysfunction during chronic amiodarone therapy. Ann Intern Med 1984; 101:28-34.
24. Martino E, Aghini-Lombardi F, Mariotti S, Bartalena L, Braverman L, Pinchera A. Amiodarone: a common source of iodine-induced thyrotoxicosis. Horm Res 1987; 26:158-171.
25. Bartalena L, Brogioni S, Grasso L, Bogazzi F, Burelli A, Martino E. Treatment of amiodarone-induced thyrotoxicosis, a difficult challenge: results of a prospective study. J Clin Endocrinol Metab 1996; 81:2930-2933.
26. Martino E, Aghini-Lombardi F, Mariotti S, et al. Treatment of amiodarone associated thyrotoxicosis by simultaneous administration of potassium perchlorate and methimazole. J Endocrinol Invest 1986; 9:201-207.
27. Reichert LJ, de Rooy HA. Treatment of amiodarone induced hyperthyroidism with potassium perchlorate and methimazole during amiodarone treatment. BMJ 1989; 298:1547-1548.
28. Wimpfheimer C, Staubli M, Schadelin J, Studer H. Prednisone in amiodarone-induced thyrotoxicosis. BMJ 1982; 284:1835-1836.
29. Broussolle C, Ducottet X, Martin C, et al. Rapid effectiveness of prednisone and thionamides combined therapy in severe amiodarone iodine-induced thyrotoxicosis. Comparison of two groups of patients with apparently normal thyroid glands. J Endocrinol Invest 1989; 12:37-42.
30. Dickstein G, Shechner C, Adawi F, Kaplan J, Baron E, Ish-Shalom S. Lithium treatment in amiodarone-induced thyrotoxicosis. Am J Med 1997; 102:454-458.
31. Brennan MD, van Heerden JA, Carney JA. Amiodarone-associated thyrotoxicosis (AAT): experience with surgical management. Surgery 1987; 102:1062-1067.
32. Meurisse M, Hamoir E, D'Silva M, Joris J, Hennen G. Amiodarone-induced thyrotoxicosis: is there a place for surgery? World J Surg 1993; 17:622-626.
33. Hintze G, Blombach O, Fink H, Burkhardt U, Kobberling J. Risk of iodine-induced thyrotoxicosis after coronary angiography: an investigation in 788 unselected subjects. Eur J Endocrinol 1999; 140:264-267.
34. Nolte W, Muller R, Siggelkow H, Emrich D, Hufner M. Prophylactic application of thyrostatic drugs during excessive iodine exposure in euthyroid patients with thyroid autonomy: a randomized study. Eur J Endocrinol 1996; 134:337-341.